Stuart A Arbuckle Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity
Stuart A Arbuckle is Director of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,000 shares of RYTM, which is worth approximately $168,360. The most recent transaction as insider was on Jun 21, 2024, when has been sold 3,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3K
0%
3M change
n/a
12M change
Total Value Held
$168,360
Stuart A Arbuckle Transaction History
Also insider at
SAA
Stuart A Arbuckle
Director
Boston, MA